Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank De Wolf

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Journal of Theoretical Biology|August 12, 2025
Preventing SARS-CoV-2 superspreading events with antiviral intranasal spraysGeorge Booth, Christoforos Hadjichrysanthou, Keira L Rice, et al.
AIDS (London, England)|April 20, 2002
Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapyRieneke M E van Praag, Ferdinand W N M Wit, Suzanne Jurriaans, et al.
AIDS (London, England)|November 25, 2011
Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohortSteven F L van Lelyveld, Luuk Gras, Anouk Kesselring, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2009
Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) CohortI Marion de Boer-van der Kolk, Mirjam A G Sprangers, Jan M Prins, et al.
Antiviral Therapy|July 1, 2010
Clinical significance of transient HIV type-1 viraemia and treatment interruptions during suppressive antiretroviral treatmentShuangjie Zhang, Ard van Sighem, Luuk Gras, et al.
Plos One|October 8, 2009
Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the NetherlandsLuuk Gras, Suzanne Jurriaans, Margreet Bakker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 18, 2008
Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohortI Marion de Boer-van der Kolk, Mirjam A G Sprangers, Marchina van der Ende, et al.
AIDS (London, England)|January 2, 2013
Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors?Annelot F Schoffelen, Steven F L van Lelyveld, Roos E Barth, et al.
AIDS (London, England)|September 21, 2012
Similar virologic response after initiation of triple-class antiretroviral therapy in primary and chronic HIV infectionMarlous L Grijsen, Rebecca Holman, Ferdinand W N M Wit, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 26, 2012
Episodes of HIV viremia and the risk of non-AIDS diseases in patients on suppressive antiretroviral therapyShuangjie Zhang, Ard van Sighem, Anouk Kesselring, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Journal of Theoretical Biology|August 12, 2025
Preventing SARS-CoV-2 superspreading events with antiviral intranasal spraysGeorge Booth, Christoforos Hadjichrysanthou, Keira L Rice, et al.
AIDS (London, England)|April 20, 2002
Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapyRieneke M E van Praag, Ferdinand W N M Wit, Suzanne Jurriaans, et al.
AIDS (London, England)|November 25, 2011
Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohortSteven F L van Lelyveld, Luuk Gras, Anouk Kesselring, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2009
Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) CohortI Marion de Boer-van der Kolk, Mirjam A G Sprangers, Jan M Prins, et al.
Antiviral Therapy|July 1, 2010
Clinical significance of transient HIV type-1 viraemia and treatment interruptions during suppressive antiretroviral treatmentShuangjie Zhang, Ard van Sighem, Luuk Gras, et al.
Plos One|October 8, 2009
Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the NetherlandsLuuk Gras, Suzanne Jurriaans, Margreet Bakker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 18, 2008
Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohortI Marion de Boer-van der Kolk, Mirjam A G Sprangers, Marchina van der Ende, et al.
AIDS (London, England)|January 2, 2013
Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors?Annelot F Schoffelen, Steven F L van Lelyveld, Roos E Barth, et al.
AIDS (London, England)|September 21, 2012
Similar virologic response after initiation of triple-class antiretroviral therapy in primary and chronic HIV infectionMarlous L Grijsen, Rebecca Holman, Ferdinand W N M Wit, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 26, 2012
Episodes of HIV viremia and the risk of non-AIDS diseases in patients on suppressive antiretroviral therapyShuangjie Zhang, Ard van Sighem, Anouk Kesselring, et al.
Pageof 11